Page last updated: 2024-08-24

zileuton and Myeloproliferative Disorders

zileuton has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Li, D; Li, S	1

Other Studies

1 other study(ies) available for zileuton and Myeloproliferative Disorders

Article	Year
The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia. Cell cycle (Georgetown, Tex.), 2009, Nov-01, Volume: 8, Issue:21 Topics: 5-Lipoxygenase-Activating Proteins; Animals; Benzamides; Carrier Proteins; Genes, abl; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Membrane Proteins; Mice; Mice, Knockout; Myeloproliferative Disorders; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2009

Article

Year

The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.

Cell cycle (Georgetown, Tex.), 2009, Nov-01, Volume: 8, Issue:21

Topics: 5-Lipoxygenase-Activating Proteins; Animals; Benzamides; Carrier Proteins; Genes, abl; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Membrane Proteins; Mice; Mice, Knockout; Myeloproliferative Disorders; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2009